MOREPENLABPharma · NSE

Morepen Laboratories in the news

Made the news 2 times since we started tracking. Newest first.

• 29 Sep 2026RegulatoryMorepen files its first US generic drug application, for diabetes drug sitagliptinMorepen Laboratories submitted its first abbreviated new drug application (ANDA) to the US FDA, for sitagliptin tablets in three strengths.
• 7 Sep 2026Business updatesFinishes the first phase of its capacity expansion ahead of scheduleThe company completed the first phase of its manufacturing capacity expansion early.